Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries

Pekcelen Y., Yavuz A., Namli S., Gucukoglu A.

BLOOD COAGULATION & FIBRINOLYSIS, cilt.16, sa.6, ss.445-446, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 6
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1097/01.mbc.0000175480.85880.e2
  • Dergi Adı: BLOOD COAGULATION & FIBRINOLYSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.445-446
  • İstanbul Üniversitesi Adresli: Hayır

Özet

A 36 year-old patient with severe haemophilia A and high-titre inhibitor underwent cataract surgery under topical anaesthesia. Recombinant factor VIIa was used only three times, once before and twice following surgery. Tranexamic acid was given concomitantly. One month after the first successful procedure on the right eye, a second operation was performed on the left eye in the same manner. Both procedures were uneventful. Neither bleeding complications nor any other side effects occurred.